Guideline Updates in Nontuberculous Mycobacterial Lung Disease Management

Read expert faculty member summaries of guideline updates in the diagnosis, monitoring, and treatment of patients with nontuberculous mycobacterial lung disease (NTM-LD).
Keira A. Cohen, MD
Program Director
person default
David E. Griffith, MD
Princy N. Kumar, MD, FIDSA, MACP
Format: Microsoft PowerPoint (.ppt)
File Size: 822 KB
Released: November 8, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Insmed Incorporated

Related Content

Prof. Sharon R. Lewin: expert insights on remdesivir for nonhospitalized adult and pediatric patients with COVID-19, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Prof. Sharon R. Lewin discusses ivermectin and the evolution of monoclonal antibody treatments during omicron, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Dr Kristen Marks on COVID-19 second booster dose: indication, which vaccine, and timing, from Clinical Care Options (CCO)

Kristen Marks, MD Released: May 20, 2022

Expert commentary on new data in RSV epidemiology from ECCMID 2022, as reported by Clinical Care Options (CCO)

Ting Shi, PhD Released: May 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings